SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-030054
Filing Date
2019-08-07
Accepted
2019-08-07 16:07:46
Documents
65
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 2019 10-Q Q2 ctmx-10q_20190630.htm   iXBRL 10-Q 2954220
2 EX-10.1 ctmx-ex101_505.htm EX-10.1 846573
3 EX-31.1 ctmx-ex311_6.htm EX-31.1 19477
4 EX-31.2 ctmx-ex312_10.htm EX-31.2 19534
5 EX-32.1 ctmx-ex321_8.htm EX-32.1 10164
6 EX-32.2 ctmx-ex322_7.htm EX-32.2 10610
7 GRAPHIC gmbmcmh3igtn000001.jpg GRAPHIC 1549
8 GRAPHIC gmbmcmh3igtn000002.jpg GRAPHIC 3299
  Complete submission text file 0001564590-19-030054.txt   9878666

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA ctmx-20190630.xsd EX-101.SCH 62111
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctmx-20190630_cal.xml EX-101.CAL 47201
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctmx-20190630_def.xml EX-101.DEF 220208
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctmx-20190630_lab.xml EX-101.LAB 408448
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctmx-20190630_pre.xml EX-101.PRE 345433
14 EXTRACTED XBRL INSTANCE DOCUMENT ctmx-10q_20190630_htm.xml XML 1549381
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37587 | Film No.: 191005504
SIC: 2834 Pharmaceutical Preparations